PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists may have received millions in duplicate funding

Virginia Tech scientists use text-mining software to find cases of duplicate funding

Scientists may have received millions in duplicate funding
2013-01-31
(Press-News.org) Big Data computation at the Virginia Bioinformatics Institute at Virginia Tech reveals that over the past two decades funding agencies may have awarded millions and possibly billions of dollars to scientists who submitted the same grant request multiple times — and accepted duplicate funding.

An analysis led by Harold R. Garner, a professor at Virginia Tech, not only indicates that millions in funding may have been granted and used inappropriately, it points to techniques to uncover existing instances of duplicate funding and ways to prevent it in the future. The analysis was presented in the comment section of this week's Nature.

Submitting applications with identical or highly similar specific aims, goals, objectives, and hypotheses is allowed; however, accepting duplicate funding for the same project is not.

To estimate the extent of double-funding, Garner and his team, including programmer Lauren McIver, systematically compared 858,717 funded grant and contract summaries using text-similarity (text mining) software followed up by manual review.

These summaries were downloaded from public websites in the U.S. for the National Institutes of Health, the National Science Foundation, the Department of Energy, the Department of Defense, and Susan G. Komen for the Cure.

Although the researchers could not definitively determine whether the similar grants were true duplicates — this would require access to the full grant files, which were not publicly available — they found strong evidence that tens of millions of dollars may have been spent on grants where at least a portion was already being funded. In the most recent five years (2007-2011), they identified 39 similar grant pairs involving more than $20 million.

"It is quite possible that our detection software missed many cases of duplication," Garner said. "If text similarity software misses as many cases of funding duplications as it does plagiarism of scientific papers we've studied, then the extent of duplication could be much larger. It could be as much as 2.5 percent of total research funding, equivalent to $5.1 billion since 1985."

Co-researcher and medical science ethicist Michael B. Waitzkin said, "In line with the Government Accountability Office report issued February 2012, these findings suggest the research community should undertake a more thorough investigation of the true extent of duplication and establish, clearer and more consistent guidance and coordination of grant and contract funding across agencies, both public and private."

The researchers did not reveal specific principal investigators or research organizations identified as double-dippers, but said that no instances of double dipping were found at Virginia Tech.



INFORMATION:



Story by Aleta Delaplane


[Attachments] See images for this press release:
Scientists may have received millions in duplicate funding

ELSE PRESS RELEASES FROM THIS DATE:

Setting the stage for a new paradigm in treatment of heart failure

Setting the stage for a new paradigm in treatment of heart failure
2013-01-31
CHAPEL HILL, N.C. – Despite a substantial increase in the number of people suffering the debilitating and often deadly effects of heart failure, treatments for the condition have not advanced significantly for at least 10 years. An analysis by researchers at the University of North Carolina School of Medicine shows new breakthroughs could be closer than we thought. The analysis points to striking similarities between heart cells in patients with heart failure and brain cells in patients with Alzheimer's disease, raising the possibility that some treatment approaches being ...

Current evidence does not support selenium for preventing heart disease in well-nourished adults

2013-01-31
A systematic review published today in The Cochrane Library finds that in well-nourished adults current evidence does not support selenium for preventing heart disease. The review suggests that taking selenium supplements does not reduce a person's risk of developing heart disease, although most evidence is currently limited to healthy American adults. Diet is a key factor influencing heart disease risk. Selenium is one dietary element that could potentially play a role in preventing heart disease by protecting against oxidative stress and inflammation. It is a common ...

Brain activity study lends insight into schizophrenia

2013-01-31
Magnetic fields produced by the naturally occurring electrical currents in the brain could potentially be used as an objective test for schizophrenia and help to better understand the disease, according to new research published today. A team of researchers from Plymouth and Spain have used the non-invasive magnetoencephalogram (MEG) technique to find two spectral features that are significantly different in schizophrenia patients compared to healthy control subjects. Furthermore, they found that there were four spectral features in the brain signals of schizophrenia ...

Dementia: Cerebrolysin shows promise

2013-01-31
Dementia patients may benefit from a promising new treatment called Cerebrolysin, according to the results of a systematic review published in The Cochrane Library. The authors brought together the most up-to-date evidence on Cerebrolysin as a treatment for vascular dementia. Vascular dementia is a common form of dementia caused by damage to the network of blood vessels supplying the brain. Some of the symptoms are similar to those associated with Alzheimer's disease and stroke but in particular those with vascular dementia often experience difficulty thinking quickly, ...

Chronic hepatitis C: Interferon may be harmful in re-treatment

2013-01-31
People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are likely to experience a variety of adverse effects, according to an updated systematic review published in The Cochrane Library. Hepatitis C affects around 170 million people worldwide. In some cases, infection leads to chronic liver disease, liver failure or liver cancer, eventually resulting in death. Treatment is based on antiviral drugs. Interferon ...

Tuberculosis: WHO-endorsed test offers rapid detection

2013-01-31
A diagnostic test for tuberculosis (TB) can accurately and quickly detect both TB and drug-resistant strains, according to a new study. The authors of a new systematic review assessing the diagnostic accuracy of the Xpert® MTB/RIF test published in The Cochrane Library say their study can provide timely advice for clinicians and policymakers in countries where TB is a major public health problem. Millions of people develop TB every year. Around 13% of cases occur in people living with HIV and more than a quarter of these people die as a result. Drug resistance is a major ...

New research shows complexity of global warming

New research shows complexity of global warming
2013-01-31
Global warming from greenhouse gases affects rainfall patterns in the world differently than that from solar heating, according to a study by an international team of scientists in the January 31 issue of Nature. Using computer model simulations, the scientists, led by Jian Liu (Chinese Academy of Sciences) and Bin Wang (International Pacific Research Center, University of Hawaii at Manoa), showed that global rainfall has increased less over the present-day warming period than during the Medieval Warm Period, even though temperatures are higher today than they were then. ...

Tuberculosis may lurk in bone marrow stem cells of infected patients, Stanford researchers say

2013-01-31
STANFORD, Calif. - Tuberculosis is a devastating disease that kills nearly 2 million people worldwide each year. Although antibiotics exist that can ameliorate the symptoms, the courses of therapy last for months and don't completely eradicate the disease, which frequently recurs years or decades after the initial treatment. Now, in a classic case of bench-to-bedside research, scientists at the Stanford University School of Medicine have discovered a possible reason for the disease's resistance: The ability of the tuberculosis bacteria to infiltrate and settle down in ...

Arunachal contributes in detecting stem cells where dormant TB bacteria hide

2013-01-31
The Idu-Mishmi community and Arunachal Pradesh appeared on the world map today for its greatest contribution in studying dormant Mycobacterium in TB that has affected nearly 4 billion people in the world and causing 1.9 million deaths yearly. In India, one person is dying of TB every 3 minutes. The study details and the contribution of Idu-Mishmis of Arunachal Pradesh and RIWATCH (Research Institute of World's Ancient Traditions Cultures and Heritage) in accomplishing the study has been duly acknowledged in a research paper published in a reputed journal 'Science Translational ...

Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently

2013-01-31
PITTSBURGH, Jan. 30, 2012 –A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations of active drug in vaginal tissue than the oral tablet, suggesting that tenofovir gel should be highly effective in protecting women against HIV transmitted through vaginal sex. Yet, as unequivocal as the study's results may be, they have not been borne out in HIV prevention trials to date, leading the researchers to ...

LAST 30 PRESS RELEASES:

Scientists show how to predict world’s deadly scorpion hotspots

ASU researchers to lead AAAS panel on water insecurity in the United States

ASU professor Anne Stone to present at AAAS Conference in Phoenix on ancient origins of modern disease

Proposals for exploring viruses and skin as the next experimental quantum frontiers share US$30,000 science award

ASU researchers showcase scalable tech solutions for older adults living alone with cognitive decline at AAAS 2026

Scientists identify smooth regional trends in fruit fly survival strategies

Antipathy toward snakes? Your parents likely talked you into that at an early age

Sylvester Cancer Tip Sheet for Feb. 2026

Online exposure to medical misinformation concentrated among older adults

Telehealth improves access to genetic services for adult survivors of childhood cancers

Outdated mortality benchmarks risk missing early signs of famine and delay recognizing mass starvation

Newly discovered bacterium converts carbon dioxide into chemicals using electricity

Flipping and reversing mini-proteins could improve disease treatment

Scientists reveal major hidden source of atmospheric nitrogen pollution in fragile lake basin

Biochar emerges as a powerful tool for soil carbon neutrality and climate mitigation

Tiny cell messengers show big promise for safer protein and gene delivery

AMS releases statement regarding the decision to rescind EPA’s 2009 Endangerment Finding

Parents’ alcohol and drug use influences their children’s consumption, research shows

Modular assembly of chiral nitrogen-bridged rings achieved by palladium-catalyzed diastereoselective and enantioselective cascade cyclization reactions

Promoting civic engagement

AMS Science Preview: Hurricane slowdown, school snow days

Deforestation in the Amazon raises the surface temperature by 3 °C during the dry season

Model more accurately maps the impact of frost on corn crops

How did humans develop sharp vision? Lab-grown retinas show likely answer

Sour grapes? Taste, experience of sour foods depends on individual consumer

At AAAS, professor Krystal Tsosie argues the future of science must be Indigenous-led

From the lab to the living room: Decoding Parkinson’s patients movements in the real world

Research advances in porous materials, as highlighted in the 2025 Nobel Prize in Chemistry

Sally C. Morton, executive vice president of ASU Knowledge Enterprise, presents a bold and practical framework for moving research from discovery to real-world impact

Biochemical parameters in patients with diabetic nephropathy versus individuals with diabetes alone, non-diabetic nephropathy, and healthy controls

[Press-News.org] Scientists may have received millions in duplicate funding
Virginia Tech scientists use text-mining software to find cases of duplicate funding